Clinical trial Recruiting at 1 site Interventional Ages 7 to 18

Social Assistance Robot to Help a Child in Prolonged Hospital Isolation

Official title: Mixed Observational Study Evaluating the Use of a Social Assistance Robot in a Population of Children Subjected to Prolonged Isolation

Run by University Hospital, Toulouse · NCT06405620 · Data updated 2026-11-12

A social-assistance robot is tested to help children in long hospital isolation and see if it improves the child’s well‑being and family connection.

More Social Isolation trials

Quick facts

Study typeInterventional
Ages7 Years to 18 Years
SexAll
Enrollment33 (estimated)
SponsorUniversity Hospital, Toulouse
Academic / other
Locations1 site (Toulouse)
StatusRecruiting
StartedJune 1, 2024
Main results expectedJuly 1, 2027
Study endsJuly 1, 2027
Registry record updatedSeptember 21, 2026
Trial IDNCT06405620 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children in the pediatric hemato-oncology unit who are expected to be in isolation for more than two weeks, with both child and parents agreeing to use the robot at home.

Probably not a fit

Children lacking sufficient French language ability or whose cognitive or motor function prevents use of the robot or interviews may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study examines whether using a social assistance robot during prolonged hospital isolation benefits pediatric patients in a hemato-oncology setting. The robot is provided to eligible children and their families, with semi-structured interviews used to gauge impact on the patient and home environment. The study focuses on iatrogenic social isolation and aims to validate whether the robot can help maintain family contact and reduce isolation-related challenges. Participant eligibility requires hospitalization in isolation for more than two weeks, parental consent, and sufficient language and cognitive abilities for participation. The trial is conducted at the Children’s University Hospital of Toulouse with leadership from University Hospital, Toulouse.

Why it matters

Potential benefit: If successful, the robot could help reduce feelings of isolation and improve contact with family during long hospital stays.

How similar studies have gone: Previous research in related settings suggests social robots can support communication and social connectedness, but results vary and this setting is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children hospitalized in the pediatric hemato-oncology department whose duration of isolation is estimated to be greater than two weeks.
* Children who have accepted the robot and whose parents have accepted its use in their home.
* Agreement of holders of parental authority for the inclusion of the hospitalized child.

Exclusion Criteria:

* Patient or two parents who do not have a sufficient level of French for research.
* Cognitive or motor disorders in children, not allowing the use of the robot and/or the carrying out of semi-structured interviews.
* Cognitive disorders in parents and/or siblings that do not allow semi-structured interviews to be carried out.

Where it's running

  • Children University Hospital of Toulouse
    Toulouse, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.